Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve Pursuant to Regulations ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences has scheduled a Board meeting on November 11, 2025, at its Ahmedabad registered office. The key item on the agenda is the approval of the Unaudited Standalone and Consolidated Financial Results for the quarter ended September 30, 2025, along with the Limited Review Report. The Board will also formally note the resignation of Company Secretary Siddhi Shah (effective September 26, 2025) and consider the appointment of Chaitra Arora (Membership No. A78376) as the new Company Secretary & Compliance Officer. The trading window for insiders has already been closed until 48 hours after the results are declared.
This is a routine board notice, but the Q2 FY26 results announcement on November 11 will be the key trigger for short-term stock movement. The company secretary transition is administrative and unlikely to materially affect the stock price.